Late-phase Clinical Trial Support Services | Charles River

late-phase clinical 

Late-phase clinical trials are designed to determine effectiveness and further study the safety of an investigational drug in human patients. At Charles River, our extensive global portfolio of support services provides complementary resources and expertise to enhance your studies.   

During Phase II, III, and IV clinical trials, a multitude of scientific and professional services are required to satisfy the regulatory requirements of drug licensing authorities. Charles River offers a wide range of clinical support services, specialty toxicology programs, process manufacturing testing, and regulatory advisory personnel to help bring your new chemical compound, biologic, or device into the marketplace. 



Discover the full range of Charles River Products and Services

For more information please call:

1.877.CRIVER.1 (1.877.274.8371)
askcharlesriver@crl.com

view all

News & Events

view all
Jul 01 Charles River Announces RMS Succes...
Jun 01 Contract Pharma: CRO Industry Upda...
Jul 06-Jul 10 Perth, Australia The 2009 Australian Society for Microbiology (ASM) A...
Aug 18-Aug 21 Charleston, SC Charles River’s Annual LAL Workshop
view all
Quality Assurance Inspector Canada - QC -...
Principal Investigator I Tacoma, WA
Sr. Quality Assurance Auditor Frederick, ...
Global Loss Control Specialist, Finance 

Charles River Laboratories, Inc.